Medical therapy for ulcerative colitis
作者： Niraj Jani , Miguel D Regueiro
DOI: 10.1016/S0889-8553(01)00010-3
关键词: Medical therapy 、 Antibiotics 、 Inflammatory bowel disease 、 Internal medicine 、 Gastroenterology 、 Curative surgery 、 Ulcerative colitis 、 Heparin 、 Medicine 、 Therapeutic approach 、 Nicotine
摘要: Although newer therapeutic agents are being developed for the treatment of inflammatory bowel disease, aminosalicylates and corticosteroids remain mainstay UC (Tables 2-5). Patients who do not respond to these or become steroid dependent require immunomodulatory therapy curative surgery. Cyclosporine represents greatest advance in 10 years. The role nicotine, heparin, antibiotics, probiotics, SCFA is less clear, but may offer an alternative approach patients intolerant nonresponsive standard therapy.
elsevier.com
sci-hub.se 参考文章(146)
Sandborn Wj, A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. The American Journal of Gastroenterology. ,vol. 91, pp. 423- 433 ,(1996)
P R Gaffney, D P Hayes, P Annis, C T Doyle, J Hogan, A Gaffney, Paradoxical response to heparin in 10 patients with ulcerative colitis The American Journal of Gastroenterology. ,vol. 90, pp. 220- 223 ,(1995)
Amitabh Prakash, Anthony Markham, Oral delayed-release mesalazine: A review of its use in ulcerative colitis and Crohn's disease Drugs. ,vol. 57, pp. 383- 408 ,(1999) , 10.2165/00003495-199957030-00013
F Feu, M Sala, J Panés, S Navarro, J Fernández, J Terés, Acute pancreatitis after long-term 5-aminosalicylic acid therapy. The American Journal of Gastroenterology. ,vol. 92, pp. 2302- 2303 ,(1997)
Adler Dj, Korelitz Bi, The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. The American Journal of Gastroenterology. ,vol. 85, pp. 717- 722 ,(1990)
V Midha, A Sood, N Sood, V Kaushal, Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial Indian Journal of Gastroenterology. ,vol. 19, pp. 14- 16 ,(2000)
N Svartz, Sulfasalazine: II. Some notes on the discovery and development of salazopyrin. The American Journal of Gastroenterology. ,vol. 83, pp. 497- 503 ,(1988)
R Bennato, G Scaglione, G N Castiglione, G Vicinanza, A D'Arienzo, F Manguso, M Sanges, G Mazzacca, Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone. Italian Journal of Gastroenterology and Hepatology. ,vol. 30, pp. 254- 257 ,(1998)
G J Mantzaris, P Kontogiannis, G Triadaphyllou, A Hatzis, Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. The American Journal of Gastroenterology. ,vol. 89, pp. 43- 46 ,(1994)
C Sninsky, P Banks, G Koval, M Safdi, T Nichols, J Deren, B Wiita, C Fleishman, L Wruble, M DeMicco, S Targan, A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. The American Journal of Gastroenterology. ,vol. 92, pp. 1867- 1871 ,(1997)